Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for Paclitaxel albumin-stabilized nanoparticle formulation in recurrent or persistent ovarian epithelial cancer, fallopian tube cancer, or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Carcinoma
• Ovarian Epithelial Cancer
• Peritoneal Carcinoma

Drugs mentioned

• Paclitaxel Albumin-Stabilized Nanoparticle Formulation (paclitaxel)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2013-12-13